Le Lézard
Classified in: Health
Subject: FEA

Medical technology companies to benefit from Picosun biocompatible materials


ESPOO, Finland, Nov. 23, 2021 /PRNewswire/ -- Picosun Group has launched a Medical Materials Library consisting of over ten materials intended for medical-related coating and encapsulation with Atomic Layer Deposition (ALD). ALD coatings are ultra-thin, and they guarantee hermetic encapsulation of virtually any implanted device.

The materials library is a reflection of over six years extensive research and development that shows ALD can render biocompatibility to a substrate coated with Picosun library materials. Biocompatibility tests were carried out according to ISO standards in accredited third-party laboratories. The performed tests included for example cytotoxicity, antimicrobial activity, skin irritation or sensitization, hemocompatibility, bacterial endotoxins, bioburden and sterilization residuals. From the tested materials Picosun is able to design tens of different types of end materials according to customer needs.

ALD technology provides dimensionless coating thus enabling miniaturization of components and devices in the field of electronic implants. Antibacterial function together with excellent barrier properties and outstanding corrosion resistance pave the way for using the materials both in electronic and orthopedic implants and show high potential in pharmaceutical packaging. The superior film uniformity and conformality ensure a pinhole-free coverage over even the smallest details of the device.

"The demonstrated results show the undisputable opportunities ALD offers to the medical sector already today. While the basic surgical principles and technologies have remained the same for decades, now ALD enables unforeseen applications potentially improving patient safety and cost-effectiveness by extending implant durability and reducing adverse effects", says Niku Oksala, professor of surgery at Tampere University and medical advisor for Picosun.

"Picosun's Medical Materials Library targeted to the medical device manufacturer segment reflects the innovative spirit of the company. I'm really excited over the fact that we are able to flexibly design tailored encapsulations according to our customers' needs. I'm especially proud of our medical customers and partners who are already in pre-clinical and clinical trials with their ALD coated devices", says Juhani Taskinen, Vice President, Medical Business Area of Picosun Group.

More information:

Juhani Taskinen
Vice President, Medical Business Area, Picosun Group
Tel: +358 50 4066 957
Email: [email protected]
www.picosun.com

Picosun provides the most advanced ALD® (Atomic Layer Deposition) thin film coating solutions for global industries. Picosun's ALD solutions enable technological leap into the future, with turn-key production processes and unmatched, pioneering expertise in the field ? dating back to the invention of the technology itself. Today, PICOSUN® ALD equipment are in daily manufacturing use in numerous leading industries around the world. Picosun is based in Finland, with subsidiaries in Germany, USA, Singapore, Japan, South Korea, China mainland and Taiwan, offices in India and France, and a world-wide sales and support network. Visit www.picosun.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/picosun-oy/r/medical-technology-companies-to-benefit-from-picosun-biocompatible-materials,c3458370

The following files are available for download:

https://mb.cision.com/Main/16058/3458370/1499851.pdf

Picosun_press_release_20211123

SOURCE Picosun Oy


These press releases may also interest you

at 09:25
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, provides an update on the initiative to...

at 09:23
To mark mental health awareness, OOt Social Health proudly launches its app to revolutionise community engagement. OOt Social Health represents a paradigm shift in fostering vibrant communities through face-to-face interactions, blending proximity,...

at 09:21
Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it had had...

at 09:20
NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein production market with the release of Andromeda X, an...

at 09:15
In the sea of content today, customers ? HCPs and consumers alike ? are overwhelmed with information. This content might be reaching them, but not effectively resonating and activating them to change behaviors. Cutting through this noise requires...

at 09:15
NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targeting the novel B7-H7/HHLA2 axis, announced today that Chief Executive Officer Ivan Cheung has been...



News published on and distributed by: